| Bioactivity | ALK2-IN-1 is a activin receptor-like kinase-2 (ALK2) inhibitor extracted from patent WO2017181117A1, Compound 876, has an IC50 of <10 nM[1]. | ||||||||||||
| Target | IC50: <10 nM (ALK2) | ||||||||||||
| CAS | 2141955-96-4 | ||||||||||||
| Formula | C31H42N6O4 | ||||||||||||
| Molar Mass | 562.70 | ||||||||||||
| Appearance | 固体 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Natasja Brooijmans, et al. Inhibitors of activin receptor-like kinase. WO2017181117A1. |
Fidrisertib
CAS: 2141955-96-4 F: C31H42N6O4 W: 562.70
ALK2-IN-1 is a activin receptor-like kinase-2 (ALK2) inhibitor extracted from patent WO2017181117A1, Compound 876, has a
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.